CME Group price target raised to $250 from $240 at Piper Sandler

Piper Sandler analyst Patrick Moley raised the firm’s price target on CME Group (CME) to $250 from $240 and keeps an Overweight rating on the shares. The firm notes CME has seen the largest growth in consensus EPS estimates among U.S. exchanges this year, but no multiple expansion.